- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Therapeutic Infliximab antibody from the biosimilar Zessly® commercial drug.
Showing all 3 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price | |
|---|---|---|---|---|---|---|---|---|---|---|
TNF alpha |
Biosimilar , Monoclonal Antibody |
Flixabi® |
10 mg/mL |
– |
2 mg |
-80°C |
01/2025 |
239,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Inflectra® |
10 mg/mL |
– |
2 mg |
- 80°C |
03/2027 |
239,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Zessly® |
10 mg/mL |
– |
2 mg |
-80°C |
10/2022 |
261,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin
Let us know about your inquiry details and we’ll contact you shortly.
